The anti-cancer potential of porcupine bezoars is primarily demonstrated by their bioactive components blocking cancer cell cycle progression, inhibiting tumor angiogenesis, and modulating the immune status of the tumor microenvironment. This multi-target mechanism of action not only effectively delays lesion progression and reduces the risk of metastasis, but also creates synergistic effects with conventional treatments: mitigating toxic side effects during chemotherapy and radiotherapy, enhancing cell repair capacity, and ultimately improving the body's internal ecological balance to control tumor burden and enhance overall quality of life, providing patients with a more comprehensive treatment support system.